Page 17

EB_ePaper_France_2016

business EUROPEAN patented AGUETTANT System® currently consists of two highly advanced devices: a ready-to-use, pre-filled plastic syringe and a multi-dose, multi-use auto-injector pen. When Laboratoire AGUETTANT 17 introduced the system five years ago, the plastic syringe received an award at the annual Pharmapack Europe conference and exhibition in Paris, the leading European event for innovative pharmaceutical packaging and drug delivery solutions. The ready-to-use injection solutions offered by Laboratoire AGUETTANT present a completely new drug delivery system. They are provided as fully drawn-up syringes. “This saves health professionals valuable time, especially in emergency situations,” Mr. Rougemond describes a major benefit of the AGUETTANT System ®. “Ready-to-use syringes are also very safe and hygienic and minimize the risk of mistakes. Last but not least, they contribute to the reduction of waste, compared to the use of ampoules containing the liquid. The preparation of readyto use injection solutions requires in-depth knowledge of the produc- Laboratoire AGUETTANT SAS 1 Rue de Alexander Fleming 69007 Lyon France  +33 478 615141  +33 478 610935  www.aguettant.com Laboratoire AGUETTANT sells the vast majority of its products to hospitals. In France and countries with its own subsidiary operations, the company serves its customers directly. In all other markets, Laboratoire AGUETTANT works together with wholesaling businesses. In the past, the pharmaceutical company was focused on the domestic market to a large extent. Only in the last few years has Laboratoire AGUETTANT developed a sizable international position. Today, the company ships 25% of its injection solutions abroad. Laboratoire AGUETTANT is a global player with subsidiaries in Europe and Asia tion process and also of the drugs themselves, particularly as regards their stability. In this area, we have accumulated great expertise and filed many patents.” Laboratoire AGUETTANT also excels in individually composed injection solutions. “Injection solutions are generally subject to very high safety and quality standards,” states Mr. Rougemond. “In the case of compositions, these standards are even higher and require even greater expertise.” The Aguettant pre-filled syringe ››› „Who we are“


EB_ePaper_France_2016
To see the actual publication please follow the link above